Hartmann + Glucose, Viaflo

Hartmann + Glucose, Viaflo is an intravenous electrolyte solution that combines potassium chloride, sodium chloride, calcium chloride dihydrate, glucose, and sodium lactate. Formulated as a sterile liquid for infusion, it provides balanced electrolytes and an energy source in a single bag. The product is marketed in the European Union and is available by prescription for clinical use in hospitals and other emergency care settings throughout the health system.

Hartmann + Glucose, Viaflo is indicated for clinical situations where fluid, electrolyte, and glucose replacement are required.

- Peri‑operative hydration and electrolyte maintenance during surgery. - Treatment of hypoglycemia when rapid glucose delivery is needed. - Replacement of fluid and electrolytes in patients with dehydration or loss due to vomiting, diarrhea, or burns. - Support of patients receiving parenteral nutrition to maintain electrolyte balance. - Management of electrolyte disturbances such as hyponatremia, hypokalemia, or hypocalcemia in acute care settings.

Adverse reactions to Hartmann + Glucose, Viaflo are generally infrequent but may occur during or after infusion.

Common: - Mild infusion‑site irritation or phlebitis. - Transient hyperglycemia. - Mild electrolyte imbalance (e.g., mild hypernatremia). - Nausea or mild gastrointestinal discomfort. - Headache. - Low‑grade fever.

Serious: - Severe allergic reaction (anaphylaxis). - Significant hyperkalemia. - Severe hypernatremia. - Fluid overload leading to pulmonary edema. - Metabolic acidosis. - Cardiac arrhythmia.

Clinicians should observe specific precautions when prescribing Hartmann + Glucose, Viaflo to ensure patient safety.

- Assess baseline electrolyte levels and blood glucose before initiation. - Use caution in patients with renal impairment or congestive heart failure due to risk of fluid overload. - Monitor serum potassium, sodium, and calcium during therapy, especially in high‑dose or prolonged infusions. - Avoid rapid infusion rates that may cause osmotic shifts or cardiac irritation. - Consider contraindications such as known hypersensitivity to any component of the solution. - Adjust dosage in pediatric or elderly patients based on weight and clinical response.

Hartmann + Glucose, Viaflo may interact with other intravenous or oral agents; awareness of potential interactions helps prevent complications.

Avoid: - Concurrent administration of other potassium‑containing solutions that could cause hyperkalemia. - Simultaneous infusion of high‑dose calcium salts, which may precipitate calcium phosphate. - Use with hypertonic dextrose solutions that could exacerbate hyperglycemia.

Use with caution: - Co‑administration with diuretics, which may alter electrolyte balance and require closer monitoring. - Concurrent use of insulin therapy, as rapid glucose delivery can affect blood sugar control. - Administration alongside nephrotoxic drugs, where fluid shifts may impact renal function.